Stargazer Pharmaceuticals (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- November 09, 2020
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $57,000,000
Company Info
- Founding Year
- 2018
- Company Description
- Stargazer Pharmaceuticals offers the therapy of standards disorder and manufacturer of pharmaceuticals products.
- Market
- Rare diseases of the eye
- Location
- Boston, MA, USA
- Coinvestors
- Canaan Partners, Novo Holdings, Pontifax, Retinal Degeneration Fund, VenBio